Compound ID | 619
Class: Macrolide (bridged bicyclic)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Excellent activities against drug resistant isolates; MICs: <0.06-0.5μg/ml - S. aureus, S. pneumoniae, S. pyrogenes and H. influenzae |
| Description: | Gai Y, Tang D, Xu G, Sun Y, Chen Z, Jiang L, et al. In vitro and in vivo evaluation of EP-14413: a novel carbamate 3,6-bicyclolide highly active against resistant pathogens. 46th-Intersci-Conf-Antimicrobial-Agents-Chemother 2006;237-238 |
| Institute where first reported: | Enanta Pharmaceuticals, USA |
| Year first mentioned: | 2007 |
| Development status: | Inactive |
| External links: | |
| Citation: |